Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Generic Silodosin 4 mg vs Urief Under Fed Conditions in Healthy Thai Male Volunteers
TCTR20220722002Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of silodosin (2 arms), sponsored by International Bio Service. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
silodosin
Beyond the preview
Go deeper on TCTR20220722002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220722002.